Related Experiment Video
Updated: May 9, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Pleiotropic effects of MORC2 derive from its epigenetic signature
Fatemeh Peymani1,2, Tomohiro Ebihara2, Dmitrii Smirnov1,2
1Institute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.
Abstract:
Heterozygous missense mutations in MORC2 have been implicated in various clinical entities, ranging from early-onset neurodevelopmental disorders to late-onset neuropathies. The mechanism underlying the phenotypic heterogeneity and pleiotropic effects of MORC2 has remained elusive. Here, we analysed blood and fibroblast DNA methylation, transcriptomes, proteomes and phenotypes of 53 MORC2 patients. We identified a MORC2-specific DNA methylation episignature that is universal across all MORC2-associated phenotypes and conserved across different tissues. The MORC2 episignature consists mainly of DNA hypermethylation in promoter regions, leading to transcriptional repression of target genes resulting in a MORC2-specific RNA signature. Concomitant downregulation of three disease-associated genes-ERCC8, NDUFAF2 and FKTN-at different levels mirrors the variable biochemical defects and clinical manifestations observed in MORC2 patients. Silencing of NDUFAF2 accounts for the Leigh syndrome manifestation, whereas dysmorphic features are due to the repression of ERCC8. Overall, we showed that pathogenic MORC2 variants cause specific episignature, whereby methylation level variability and its repression impact on target genes explains the pleiotropy and predicts phenotypic heterogeneity in MORC2-related disorders. We predict that epigenetic variation may underlie pleiotropy in other Mendelian disorders.
Insights
Pathogenic variants in MORC2 cause a DNA methylation signature, leading to gene repression and varied symptoms in patients. This epigenetic change explains the diverse clinical outcomes in MORC2-related disorders.
Area of Science:
- Genetics
- Epigenetics
- Molecular Biology
Background:
- Heterozygous missense mutations in MORC2 are linked to diverse clinical conditions, from early neurodevelopmental issues to late-onset neuropathies.
- The underlying mechanisms for the wide range of symptoms and pleiotropic effects of MORC2 mutations remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms behind the phenotypic heterogeneity in MORC2-related disorders.
- To identify a potential epigenetic link explaining the pleiotropic effects of MORC2 mutations.
Main Methods:
- Analysis of DNA methylation, transcriptomes, proteomes, and clinical phenotypes in 53 patients with MORC2 mutations.
- Utilized multi-omics data to correlate molecular changes with clinical manifestations.
Main Results:
- Identified a universal MORC2-specific DNA methylation episignature across all phenotypes and tissues.
- Observed DNA hypermethylation in promoter regions, leading to transcriptional repression and a distinct RNA signature.
- Downregulation of ERCC8, NDUFAF2, and FKTN correlated with specific clinical features like Leigh syndrome and dysmorphic features.
Conclusions:
- Pathogenic MORC2 variants induce a specific DNA methylation episignature, explaining the pleiotropy and phenotypic heterogeneity.
- Epigenetic variations, particularly DNA methylation changes, are proposed as a key mechanism for pleiotropy in MORC2 disorders and potentially other Mendelian conditions.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Master Transcription Regulators
Pleiotropy
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Position-effect Variegation
Epistasis